Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Ethical, legal, and social implications of AI-enabled digital therapeutics: A comparative analysis of risk-based regulatory frameworks in the European Union and Japan.

PMID: 42037982 · 2026

JournalDigital health
Year2026
PMID42037982

Abstract

Digital therapeutics (DTx) and other forms of therapeutic artificial intelligence (AI) are becoming increasingly embedded in healthcare systems and everyday health practices. Unlike earlier forms of medical AI, which mainly support diagnostic decision-making, therapeutic AI systems interact continuously with patients and may influence health-related behaviour over time. These characteristics raise ethical, legal, and social implications (ELSI) that extend beyond conventional concerns about safet

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.